459 related articles for article (PubMed ID: 21941546)
21. Progress made in the use of animal models for the study of high-risk, nonmuscle invasive bladder cancer.
Lin-Tsai O; Taylor JA; Clark PE; Adam RM; Wu XR; DeGraff DJ
Curr Opin Urol; 2014 Sep; 24(5):512-6. PubMed ID: 24921908
[TBL] [Abstract][Full Text] [Related]
22. Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium.
Goebell PJ; Knowles MA
Urol Oncol; 2010; 28(4):409-28. PubMed ID: 20610279
[TBL] [Abstract][Full Text] [Related]
23. Chemoprevention of bladder cancer.
Grossman HB
Urology; 2006 Mar; 67(3 Suppl 1):19-22; discussion 23-4. PubMed ID: 16530070
[TBL] [Abstract][Full Text] [Related]
24. The untapped potential of genetically engineered mouse models in chemoprevention research: opportunities and challenges.
Abate-Shen C; Brown PH; Colburn NH; Gerner EW; Green JE; Lipkin M; Nelson WG; Threadgill D
Cancer Prev Res (Phila); 2008 Aug; 1(3):161-6. PubMed ID: 19138951
[TBL] [Abstract][Full Text] [Related]
25. [Recent advances in bladder urothelial carcinogenesis].
Pignot G; le Goux C; Bieche I
Bull Cancer; 2015 Dec; 102(12):1020-35. PubMed ID: 26617115
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and etiology of premalignant and malignant urothelial changes.
Cohen SM; Shirai T; Steineck G
Scand J Urol Nephrol Suppl; 2000; (205):105-15. PubMed ID: 11144890
[TBL] [Abstract][Full Text] [Related]
27. Animal models of urinary bladder cancer and their application to novel drug discovery.
Oliveira PA; Arantes-Rodrigues R; Vasconcelos-Nóbrega C
Expert Opin Drug Discov; 2014 May; 9(5):485-503. PubMed ID: 24670247
[TBL] [Abstract][Full Text] [Related]
28. Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications.
Osborne C; Wilson P; Tripathy D
Oncologist; 2004; 9(4):361-77. PubMed ID: 15266090
[TBL] [Abstract][Full Text] [Related]
29. Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans.
Knapp DW; Dhawan D; Ramos-Vara JA; Ratliff TL; Cresswell GM; Utturkar S; Sommer BC; Fulkerson CM; Hahn NM
Front Oncol; 2019; 9():1493. PubMed ID: 32039002
[TBL] [Abstract][Full Text] [Related]
30. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions].
Sibony M; Billerey C
Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498
[TBL] [Abstract][Full Text] [Related]
31. Molecular alterations in bladder cancer.
Cordon-Cardo C
Cancer Surv; 1998; 32():115-31. PubMed ID: 10489625
[TBL] [Abstract][Full Text] [Related]
32. Bladder cancer: translating molecular genetic insights into clinical practice.
Cheng L; Zhang S; MacLennan GT; Williamson SR; Lopez-Beltran A; Montironi R
Hum Pathol; 2011 Apr; 42(4):455-81. PubMed ID: 21106220
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms in urinary bladder carcinogenesis.
Volanis D; Papadopoulos G; Doumas K; Gkialas I; Delakas D
J BUON; 2011; 16(4):589-601. PubMed ID: 22331708
[TBL] [Abstract][Full Text] [Related]
34. Use of selenium in chemoprevention of bladder cancer.
Brinkman M; Buntinx F; Muls E; Zeegers MP
Lancet Oncol; 2006 Sep; 7(9):766-74. PubMed ID: 16945772
[TBL] [Abstract][Full Text] [Related]
35. Research progress of oncogene and tumor suppressor gene in bladder cancer.
Zhang X; Han C; He J
Panminerva Med; 2015 Dec; 57(4):191-200. PubMed ID: 25634585
[TBL] [Abstract][Full Text] [Related]
36. [Gene-regulating chemoprevention against cancer--as a model for "molecular-targeting prevention" of cancer].
Sowa Y; Sakai T
Nihon Eiseigaku Zasshi; 2003 May; 58(2):267-74. PubMed ID: 12806965
[TBL] [Abstract][Full Text] [Related]
37. Experimental models of gene-environment interaction for cancer chemoprevention studies.
Hursting SD
Curr Opin Oncol; 1997 Sep; 9(5):487-91. PubMed ID: 9327228
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetics of bladder cancer: targets for diagnosis and therapy.
Baffa R; Letko J; McClung C; LeNoir J; Vecchione A; Gomella LG
J Exp Clin Cancer Res; 2006 Jun; 25(2):145-60. PubMed ID: 16918124
[TBL] [Abstract][Full Text] [Related]
39. Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis.
van der Horst G; van Asten JJ; Figdor A; van den Hoogen C; Cheung H; Bevers RF; Pelger RC; van der Pluijm G
Eur Urol; 2011 Aug; 60(2):337-43. PubMed ID: 21616583
[TBL] [Abstract][Full Text] [Related]
40. Isothiocyanates in the chemoprevention of bladder cancer.
Tang L; Zhang Y
Curr Drug Metab; 2004 Apr; 5(2):193-201. PubMed ID: 15078196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
